Imatinib Mesylate (Gleevec; STI571) Monotherapy Is Ineffective in Suppressing Human Anaplastic Thyroid Carcinoma Cell Growth<i>in Vitro</i>

Joshua M. Dziba(Lexington VA Health Care System), Kenneth B. Ain(University of Kentucky)
The Journal of Clinical Endocrinology & Metabolism
May 1, 2004
Cited by 32


Related Papers

No related papers found

Powered by citation graph analysis